Tyverb and disease progression Patient Reports February 11, 2012

Tyverb Side Effects Report #5714617-5
Tyverb side effect was reported by a Physician from SWITZERLAND on Apr 14, 2008. Female patient was diagnosed with breast cancer metastatic, thrombosis and was treated with Tyverb. After drug was administered, patient experienced the following side effects: cerebral haemorrhage, disease progression, metastases to central nervous system, peripheral ischaemia, renal failure, thrombosis. Tyverb dosage: 1250MG PER DAY. During the same period patient was treated with FRAXIFORTE, FRAGMIN, FRAXIPARINE, XELODA. Patient died on 01/13/2008.

Tyverb Side Effects Report #5651076-5
Tyverb side effect was reported by a Physician from SWITZERLAND on Feb 29, 2008. Female patient was diagnosed with breast cancer  and was treated with Tyverb. After drug was administered, patient experienced the following side effects: cerebral haemorrhage, disease progression. Tyverb dosage: 1250MG PER DAY. During the same period patient was treated with FRAXIFORTE, FRAGMIN, XELODA. Patient died on 01/13/2008.

Tyverb Side Effects Report #5873695-3
Tyverb side effect was reported by a Physician from FRANCE on Aug 28, 2008. Female patient, 63 years of age, was treated with Tyverb. After drug was administered, patient experienced the following side effects: disease progression, thrombocytopenia. Tyverb dosage: 1250MG PER DAY. During the same period patient was treated with XELODA. Patient died.